logo
'Rescued' CASC Bar reopens as Whisky Situation Aberdeen

'Rescued' CASC Bar reopens as Whisky Situation Aberdeen

A new Aberdeen bar serving more than 700 different bottles of whisky is opening today, at the venue previously known as CASC Bar.
Whisky Situation Aberdeen, the brainchild of 37-year-old Carlos Yabrudy, promises an exclusive whisky offering, as well as cigars, beer, wine and cocktails.
The new owners of the the Stirling Street bar, opening on Friday at 5pm, hope it will become a tourist destination in Aberdeen.
'We want to eventually become the best whisky bar in Scotland,' Carlos says.
'We want people to say: 'when you go to Scotland, that's where you need to go'.
'That's the goal.'
CASC Bar closed its doors back in December 2024 after 11 years on the Aberdeen food and drink scene.
Carlos – who founded retail company Whisky Situation back in 2023 – has retained several members of staff in his bid to 'rescue' the city centre venue.
He adds: 'I found out about this place, and when things were on the rocks I met the old manager and decided to rescue the place. And in doing so, saved three jobs and brought in three more staff members on top of that.
'For a lot of locals, this place was their second home.
'Hence there was a lot of sadness in the closing.'
Carlos believes that his new bar – and its sister whisky shop on King Street – could help improve Aberdeen city centre.
He says: 'Aberdeen is always playing third fiddle to Glasgow and Edinburgh, isn't it?
'Aberdeen has a lot here – Tall Ships and a lot of festivals.
'It's a city that works more like a town, where people talk more than other places. It's not so disconnected.
'Aberdeen is the closest to distilleries, on the cusp of Speyside – close to Macallan and Tomatin.
'People should be coming here from all over the world.
'Now there is an even better reason for them to come to the city centre. And hopefully start driving the city's regeneration.'
The new bar will host private events including weekly tastings from distilleries like Tomatin and Lochlea.
The range of whisky on offer is exclusive, says Carlos, with many bottles unavailable elsewhere in the UK.
'The main draw is having over 700 whiskies for people to try,' adds Carlos.
'We can give people the opportunity to try different things.
'A lot of this isn't available to taste before people buy it. So this will be a hub for people to try the newest GlenAllachie or Lochlea.'
Unique bottles available to sample include Brother's Bond straight bourbon whiskey from actors Ian Somerhalder and Paul Wesley, and Japanese whiskey from Yamazaki Distillery.
Also boasting the 'largest humidor in Scotland', the bar offers a range of cigars.
Drams will range from £4.50 to over £100 at Whisky Situation Aberdeen.
'We can open a bottle that costs £200 per dram, it depends what people ask for,' he adds.
'I'm a very flexible guy. It's not a problem.'
Bottles like the single cask Glenfarclas Family Cask range might be more pricy for a dram.
Carlos adds: 'You're looking at £8,000 per bottle.
'So if you divide them up, that's about £200-300 per single [dram].'
The team are looking forward to opening the new bar and King Street shop this evening.
Carlos says: 'I'm excited to have everyone down.
'It feels like your family coming to see you again when you haven't seen them for a long time.
'The atmosphere won't be clinical – or like a dank student bar – but rather a familiar place.'
There are plans for refurbishment further down the line to turn the bar into a 'speakeasy style' venue.
The new King Street whisky shop will be open Tuesday to Saturday.
The Stirling Street bar will be open daily 3pm to 12am Sunday-Thursday, and till 1am Friday and Saturday.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

$2 billion medical donation had me dreaming of paralysis cure
$2 billion medical donation had me dreaming of paralysis cure

The National

time13 hours ago

  • The National

$2 billion medical donation had me dreaming of paralysis cure

The Knights are no strangers to medical causes. A decade ago, they matched $500 million raised for the same institute, doubling its resources overnight. Now, working alongside Dr. Brian Druker a pioneer who revolutionised cancer treatment through targeted therapies they've taken that commitment to a level few could have imagined. Their aim is simple but staggering: to transform how we understand, treat, and ultimately cure cancer. It's a long way from where Knight began. In his memoir Shoe Dog, he recalls the early days in 1964, selling Japanese running shoes from the back of his Plymouth Valiant. That tiny venture became Nike, a company now worth billions, built on the belief that sport can change lives. Knight's business story is a lesson in vision and persistence. His philanthropy suggests he believes science can be driven the same way. I read about Knight's gift on the same day I went for physiotherapy. As I worked through my exercises coaxing my stubborn leg into action my mind wandered to the same place it often goes when I hear news of medical breakthroughs. What if there was a cure for paralysis? What if the messages from my brain to my leg flowed freely again, the broken bridge in my nervous system rebuilt? I imagine standing up without a thought, my body suddenly fluent in movements it has long forgotten. In my mind, I'd turn into a kind of Superman not the cape-wearing, planet-saving sort, but the kind who makes up for lost time with a vengeance. I'd run until my lungs burned, play sport until the sun set, walk miles just because I could. I'd board a plane without wondering about access, climb mountains, dive into oceans, and dance on cobbled streets somewhere far from home. I wouldn't stop. It's a fantasy, but one rooted in the same force that fuels Knight's gift: hope. Read more: Cancer and paralysis aren't the same, but they share a brutal truth, both can strike without warning, both can strip away the life you once knew, and both create a hunger for breakthroughs that feels almost primal. I've lost friends to cancer. I know people living in the limbo of waiting for better treatments. And I know my own quiet ache for a cure, the way it sits with me every day, sometimes loud, sometimes barely a whisper. That's why stories like this matter. They're not just about money; they're about momentum. Science is often portrayed as a slow, careful march, but the right funding can turn it into a sprint. Knight's donation will pay for labs, equipment, trials, and the kind of bold, risky research governments often won't touch. It can draw in brilliant minds from around the world and give them the freedom to chase ideas that might otherwise remain trapped in grant applications. Of course, $2 billion won't cure cancer tomorrow. But it will close the gap between where we are and where we dream of being. And maybe just maybe the breakthroughs made possible in oncology will ripple outwards into other areas of medicine. Advances in gene editing, cell therapy, and neuroregeneration could one day be applied to paralysis. I left physio tired but strangely energised. I thought about Knight, about Dr. Druker, about the patients whose lives might be extended or saved because one man decided to write the biggest cheque of his life. I thought about the people who will never meet him but will feel the impact of his gift. And I thought about my own 'what if' not as an impossible dream, but as a possibility that's just waiting for its turn. In Shoe Dog, Knight wrote: 'I wanted to build something that was my own, something I could point to and say: I made that. It was the only way I saw to make life meaningful.' It's clear that for him, meaning now comes not just from shoes and sport, but from putting the weight of his fortune behind the hardest problems in medicine. We need more of that from billionaires, from companies, from governments, and from ordinary people giving what they can. Medical revolutions don't happen in isolation. They're built from thousands of contributions, from lab bench to bedside. Knight's gift is historic, but it's also a reminder that progress is a team effort. Until the day science answers my 'what if,' I'll keep doing my rehab. I'll keep pushing through the ache, because every step I take now makes me ready for the steps I hope to take in the future. And I'll keep believing stubbornly, unapologetically that cures for both cancer and paralysis are out there, waiting for us to find them. Because if Phil Knight can take the biggest swing of his life for cancer research, the rest of us can keep showing up for our own battles. Hope, after all, is contagious and with that mindset I challenge you today to go and move your body in the beauty of nature for all those who can't and to remind yourself 'Be where your feet are'

Dollar slips before data, yen outperforms, eyes on Trump-Putin meeting
Dollar slips before data, yen outperforms, eyes on Trump-Putin meeting

Reuters

timea day ago

  • Reuters

Dollar slips before data, yen outperforms, eyes on Trump-Putin meeting

Aug 15 (Reuters) - The dollar slipped on Friday with investors cautious about the rate outlook ahead of import price data, after recent figures suggested inflation could accelerate in the coming months. The yen outperformed the euro and the pound following the release of surprisingly strong Japanese growth data, which showed export volumes held up well against new U.S. tariffs. All eyes will be on a meeting in Alaskalater on Friday between Donald Trump and his Russian counterpart Vladimir Putin, focused on the U.S. president's push to seal a ceasefire deal on Ukraine. U.S. import price figures will be more closely watched than usual after data on Thursday showed a sharp jump in producer prices last month, pushing the dollar higher. If import prices keep rising, it may signal that U.S. companies are fully absorbing the tariffs, leaving them with two options: pass the costs on to consumers, potentially stoking inflation, or take the hit to profit margins. Money markets reflect a 95% chance of a 25-basis point Fed rate cut in September. They fully priced a 25-bp cut and a 5% chance of a larger 50-bp move before Thursday's U.S. data. Markets also await next week's Jackson Hole symposium for clues on the Fed's next move. Signs of weakness in the U.S. labour market combined with inflation fromtrade tariffs could present a dilemma for the Fed's rate cut trajectory. The U.S. dollar index , that measures the value of the greenback relative to a basket of six major foreign currencies, was down 0.33% at 97.882. However, it's not just a matter of rate outlook divergence according to some analysts. Morgan Stanley estimates that the dollar risk premium is currently 6% compared to a range of 5% to 9% since April. The bank sees ample scope for it to return to, or even exceed, those peaks, potentially weakening the U.S. currency, because investors are increasing the share of their U.S. asset exposure that is hedged against exchange rate risks. After Trump's so-called Liberation Day tariff announcements, markets sold off U.S. assets, including the greenback, on fears that Washington was about to launch a trade war against its major allies. The yen was up 0.56% against the dollar at 146.94, helped by data showing Japan's economy grew much faster than expected in the second quarter. U.S. Treasury Secretary Scott Bessent's remarks earlier this week that the Bank of Japan could be "behind the curve" in dealing with the risk of inflation proved to be another tailwind for the yen. "Although BoJ Governor Ueda may choose to disregard Bessent's remarks, the Japanese authorities will not want the value of the yen to become more of a concern to the Trump administration than it already is," said Jane Foley senior forex strategist at RaboBank. The euro rose 0.34% versus the dollar to $1.1687. Most analysts expect Europe's single currency to benefit from any ceasefire deal in Ukraine. "The Trump-Putin meeting and any better clarity on the path ahead in the Ukraine conflict have longer-lasting implications for the euro than for the dollar," said Francesco Pesole, forex strategist at ING. "There is a chance that today might be the first step in the direction of de-escalation, and markets may tread carefully for now," he added. The pound was up 0.24% against the U.S. currency at $1.3563. The Australian dollar was up 0.25% versus the greenback at 0.6512. Elsewhere, bitcoin and ether rose after dropping about 4% each on Thursday. Bitcoin had at one point touched a record high on Thursday on shifting Fed rate-cut expectations.

World shares mixed ahead of meeting between Trump and Putin
World shares mixed ahead of meeting between Trump and Putin

Rhyl Journal

time2 days ago

  • Rhyl Journal

World shares mixed ahead of meeting between Trump and Putin

Bitcoin briefly rose more than 3% to a new record of over 123,000 dollars, according to CoinDesk. It later fell back below 122,000 dollars. The future for the S&P 500 was unchanged, while that for the Dow Jones Industrial Average edged 0.1% higher. Later Thursday, a report will show how bad US inflation was at the wholesale level across the US. Economists expect it to show inflation ticked up to 2.4% in July from 2.3% in June. In early European trading, Germany's DAX rose 0.5% to 24,296.02. In Paris, the CAC 40 added 0.4% to 7,832.60. Europe is bracing for Mr Trump's encounter with Mr Putin, though the US president has said he will prioritise trying to achieve a ceasefire in Ukraine when he meets with Mr Putin on Friday in Anchorage, Alaska. The Trump-Putin meeting could have major implications for energy markets, potentially leading to an easing of sanctions against Moscow, or an escalation if no progress is made on ending the war in Ukraine. Early on Thursday, US benchmark crude rose 28 cents to 62.93 dollars per barrel. Brent crude, the international standard, added 32 cents to 65.95 dollars per barrel. During Asian trading, Tokyo's Nikkei 225 fell nearly 1.5% to 42,649.26 as investors sold to lock in recent gains that have taken the benchmark to all-time records. The Japanese yen rose against the dollar after US treasury secretary Scott Bessent said in an interview with Bloomberg that Japan was 'behind the curve' in monetary tightening. He was referring to the slow pace of increases in Japan's near-zero interest rates. Low interest rates tend to make the yen weaker against the dollar, giving Japanese exporters a cost advantage in overseas sales. The dollar fell to 146.50 Japanese yen Thursday, down from 147.39 yen. The euro slid to 1.1681 dollars from 1.1705 dollars. In Chinese markets, Hong Kong's Hang Seng index shed 0.4% to 25,519.32, while the Shanghai composite index slid 0.5% to 3,666.44. South Korea's Kospi rose less than 0.1% to 3,225.66. In Australia, the S&P ASX 200 index added 0.5% to 8,873.80. Taiwan's Taiex fell 0.5% and India's Sensex edged 0.2% higher. On Wednesday, US stocks ticked higher, extending a global rally fuelled by hopes the Federal Reserve will cut US interest rates. The S&P 500 rose 0.3% and the Dow climbed 1%. The Nasdaq composite added 0.1%. Treasury yields eased in the bond market in anticipation that the Fed will cut its main interest rate for the first time this year at its next meeting in September. Lower rates can boost investment prices and the economy by making it cheaper for US households and businesses to borrow to buy houses, cars or equipment, though they risk worsening inflation. Mr Trump has angrily been calling for cuts to help the economy, often insulting the Fed chairman Jerome Powell while doing so. But the Fed has hesitated, worried that Mr Trump's sweeping higher tariffs could make inflation much worse. Fed officials have said they want to see more fresh data about inflation before moving.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store